Tirzepatide Pen – Research Peptide Pen

Tirzepatide Pen – Research Peptide Pen

Tirzepatide Pen is a ready-to-use research formulation supplied for laboratory use. Available in 10 mg and 20 mg strengths, each pen is manufactured to high quality standards and supported by HPLC purity verification and Certificate of Analysis.

The pre-filled pen format is designed for consistent handling within controlled laboratory environments. Tirzepatide is a dual GIP and GLP-1 receptor agonist peptide commonly examined in studies related to metabolic regulation and endocrine signalling pathways.

For research use only. Not intended for human consumption, medical, therapeutic, diagnostic, or veterinary use.

Product Specifications

• Compound: Tirzepatide
• Type: Synthetic research peptide (dual GIP/GLP-1 receptor agonist)
• Format: Ready-to-use research pen
• Strengths: 10 mg / 20 mg
• Purity: ≥99% (see batch Certificate of Analysis)
• Documentation: Certificate of Analysis (COA) available
• Supply: UK dispatch

Research Background

In laboratory and preclinical research settings, Tirzepatide is commonly investigated in studies involving:

• GIP and GLP-1 receptor signalling pathways
• Metabolic and endocrine research models
• Peptide-receptor interaction studies

Related products: Tirzepatide vial | Semaglutide Pen  | Retatrutide

Handling & Storage

• Refrigerate between 2°C and 8°C
• Do not freeze
• Protect from direct sunlight

Always refer to the product-specific or batch-specific documentation and follow your institutional laboratory protocols.

See also: How to Store Research Peptides

Research Use Notice

Tirzepatide Pen is supplied strictly for laboratory research and analytical purposes. It is not a medicine and is not intended for human or veterinary use. Purchasers must be 18 years or older and are responsible for lawful handling within a research setting.